HAEMATOLOGY
CBC -(COMPLETE BLOOD COUNT)
RBC PARAMETERS
HB -(Haemoglobin)
10.2
g/dL
13.0-18.0
Erythrocyte Count (RBC Count)
4.18
10^6/uL
4.0-5.2
Packed Cell Volume (PCV)-Hematocrit
36.0
%
34.0-40.0
Mean Corpuscular Volume (MCV)
86.2
fL
80 - 96
Mean Corpuscular Hemoglobin (MCH)
24.3
pg/cell
28 - 33
Mean Corpuscular Hb concentration (MCHC)
28.2
g/dL
31 - 36
RDW-CV
17.3
%
11.7 - 14.4
RDW-SD
53.2
fL
35.0- 46.0
WBC PARAMETERS
Total Leukocyte Count (TLC/WBC)
13700
/cumm
4000-11000
Differential Count of WBC
Polymorphs Neutrophil
68
%
30 - 70
Lymphocytes
28
%
30 - 50
Eosinophils
02
%
1 - 5
Monocytes
02
%
0 - 6
Basophil
00
%
0 - 1
ABSOLUTE LEUKOCYTE COUNTS
Absolute Neutrophil Count
9316.00
/cumm
1800-7800
Absolute Lymphocyte Count
3836.00
/cumm
1000-4800
Absolute Eosinophils Count
274.00
/cumm
0-450
Absolute Monocyte Count
274.00
/cumm
0-800
Absolute Basophil Count
0.00
/cumm
0-200
PLATELET PARAMETERS
Platelet Count
2.42
lakh/cumm
1.5-5.0
Mean Platelet Volume (MPV)
10.3
fL
7.10-12.50
PCT(Plateletcrit)
0.249
%
0.18 - 0.39
Platelet Distribution Width(PDW)
16.1
fL
8.30-18.0
 
Erythrocyte Sedimentation Rate
40
mm/hr
0 - 20
ESR

Methodology: Sedimentation

Factors increasing ESR -Old age -Pregnancy -Anemia -Elevated fibrinogen -Macrocytosis 

Factors decreasing ESR -Microcytosis -Low fibrinogen -Polycythemia -Marked leukocytosis

BIOCHEMISTRY
C-Reactive Protein(C R P)
3.0
mg/l
< 6 mg/l
Comment

METHOD: IMMUNOTURBIDIMETRIC


 The C -Reactive protein is normal alpha- globulin and it is elevated in patients who have an inflammatory conditions of infectious or noninfectious origin. The test is non specific and the resuts frequently overlap ESR values. The findings can be useful as a simple index of the disease ativity and treatment status.

LFT (LIVER FUNCTION TEST)
Billirubin (Total & Direct & Indirect)
Total Billirubin
0.69
mg/dl
Adult: 0.1 - 1.2 mg/dl
Direct Billirubin
0.24
mg/dl
0 - 0.3 mg/dl
Indirect Billirubin
0.45
mg/dl
0.2 - 0.7 mg/dl
Serum SGOT(AST)
33.0
IU/L
10-40
Serum SGPT(ALT)
25.0
IU/L
5 - 40 IU/L
Alkaline Phosphatase
98.0
IU/L
Female : 64-306 IU/L
Total Protein (A:G)
Serum Protein
6.10
gm/dl
6.3 - 8.4 gm/dl
Albumin
3.40
gm/dl
3.5 - 5.0 gm/dl
Globulin
2.70
gm/dl
2.5 - 3.5 gm/dl
A:G Ratio
1.26
Ratio
1.5 - 3.1
KFT (KIDNEY FUNCTION TEST)
Blood Urea
28.0
mg/dl
05 - 43
Blood Urea Nitrogen(Bun)
13.08
mg/dl
7 - 21 mg/dl
Comment

Elevated levels of blood urea nitrogen are observed in pre renal , renal and post renal conditions .
Pre renal conditions .. diabetes mellitius, dehydration, cardiac failure , hematemesis, severe burns, high fever etc..
Renal conditions.. disease of kidneys.
Post renal conditions.. inlargement of prostate, stones in the urinary tract, tumor of the bladder . Decreased values have been reported in severe liver disease, protein malnutrition & pregnency.

Serum Creatinine
0.96
mg/dl
0.6 - 1.2
Comment

Decreased serum calcium values are found in hypoparathyroidism, rickets, osteiomalacia and steatorrhea. A fall in serum calcium can occun in acute pancreatitis and in those forms of renal disease in which excessive proteinuria is observed. Increased serum calcium values are observed in hyperparathyroidism, hypervitamonosis D and multiple myeloma.

Serum Uric Acid
3.61
mg/dl
2.5-6.8
Comment

Uric acid is the end product of nucleoprotein metabolism. It is a low threshold excretory product. the serum uric acid level is ofter raised in gout. the determination has diagnostic value differentiating gout from non gout arthritis. uric acid levels are also increased in renal failure, uremia and leukemia.

Serum Sodium(Na+)
135.0
mEq/L
136 - 148 mEq/L
Serum Potassium(K+)
4.20
mEq/L
3.6 - 5.5 mEq/L
Serum Chloride(Cl-)
103.0
mEq/L
94 - 110 mEq/L
Comment

 

 

 

 

 

LIPID PROFILE
Serum Total Cholesterol
129.0
mg/dl
Desirable: < 200
Serum Triglycerides
174.0
mg/dl
Desirable: < 160
Serum H.D.L. - Cholesterol
47.0
mg/dl
Desirable: > 60
Serum L.D.L. - Cholesterol
82.0
mg/dl
Desirable: < 130
Serum V.L.D.L Cholesterol
34.8
mg/dl
Desirable: < 23
Total Choles. / H.D.L Ratio
2.7
Ratio
Low Risk: 3.3 - 4.4
L.D.L. / H.D.L. Ratio
1.7
Ratio
Low Risk: 0.5 - 3.0
Comment

 

NOTE  :- Lipid profile range as per ncep – atp 111 are :

Serum cholestrol  (Total) :

Desirable: < 200 mg/dl, Borderline: 200-239 mg/dl, Elevated : >250 mg/dl.

Serum high – density lipoprotein cholterol (HDL):

Desirable: > 60 mg/dl,  Borderline: 40-60 mg/dl, Elevated : >70 mg/dl.

TOTAL cholestrol : HDL cholestrol:

Low risk :  3.3 - 4.4, Average risk : 4.4 – 7.1, Moderate risk : 7.1 – 11.0, High risk : >11.0

Serum low – density lipoprotein (LDL) cholesterol:

Desirable : < 100 mg/dl, Borderline: 100-159 mg/dl, Elevated : >160 mg/dl.

* It is ptreferable to measure lipid after 12 hrs fasting, as triglyceride levels rised and both HDL & LDL levels fall after fat containing meals.

* since serum lipid levels a vary widely from day to day( being largely dependaent on diet) , at least 2 - 3 measurments should be made days or weeks apart , before labelling a person as hyper lipidaemic/ normolipidaemic or before initiating therapy.
*Both LDL & HDL levels remains decreased for several weeks after acute inflammatory states, following myocardial infection, stress, trauma, surgery and recent illness.
* lipid profile values should always be corroborated in the light of clinical findings, dietary habits / axcess/ restrictions, effects of illness, exercise, inter & intra individual variations and drugs( Anabolic steroids, oral contraceptives) progestogens, antithypertensives, oestrogen, insulin & hydrochlorthiazide.

Plasma Glucose (Random)
82.0
mg/dl
70 - 140
Glycosylated Haemoglobin
HbA1c
6.1
%
Normal: Below 6.0 %
Mean Blood Glucose (Calculated)
128.37
mg/dl
Comment

METHOD :- HPLC for HbA1C  by LD 500 (AspenA1c)

(NGSP Certified)


Glycosylated Haeamoglobin Blood :-

Current methods of assessing control in patient with diabtes mellitus include measurement of blood and plasma. These glucose measurements reflect acute changes and not the long term aspects of diabetic control. A more useful technique for assessing the control of diabetes is the measurement of glycosylated haemoglobins that is haemoglobin with glucose or glucose phosphate moieties bound to the amino terminal valine of one or both beta chaings.

The level of haemoglobin Alc, which comose 3% to 6% of the total haemoglobin in healthy individuals is proportional to both the average glucose concentration and the life span of the red blood cells in the circulation.The measurement or HbA1C has therefore been accepted for the clinical management of diabetes through routine monitoring.

Increased level of HbA1C correlate  with lack of glucose control. In diabetics with good glucose control the amount of HbA1C may return to the reference interval. specimens for patients with hemolytic anemia  will exhibit decrease glycosylated haemoglobin values due to shorted life span of the red cells.

specimens from patients with polycythemia or post-splenectomy may exhibit increase glycosylated haemoglobin values due to a somewhat longer life span of the red cells.